Press Releases

Pronalyse’s Fusion Protein Characterization Service Aids in the Drug Development Process

Creative Proteomics Lipidomics Launches Ceramides Analysis Service

Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service

Diagnostics for the Real World’s landmark SAMBA machine enters Science Museum Group’s permanent collection and features in major new “Injecting Hope” exhibition

Diagnostics for the Real World (DRW), innovator of the SAMBA platforms for rapid point-of-care detection of infectious diseases, today announces that the SAMBA device will be on public display at the Science Museum’s major new free exhibition “Injecting Hope: The race for a COVID-19 vaccine”, which runs from 30 November 2022 – 07 January 2024.

Biopharma PEG Develops PEG Products For Click Chemistry

Huateng Pharma Supplies Semaglutide Intermediates Against Type 2 Diabetes

FORS MARSH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH SERA PROGNOSTICS

Creative Enzymes Provides DNA Molecular Weight Markers and Ladders

CD Genomics Expands Its Sequencing Portfolio with the Launch of Whole Exome Sequencing

MicrobioSeq Boosts Scientific Research with Gene Expression Analysis

Zebrafish Disease Model: Developed by Creative Biogene to Support Multiple Therapeutic Areas

Microbiosci Develops Data-independent Acquisition Proteomics to Support Molecular Diagnostics

Creative Bioarray Develops More Than 1000 Cell Types Together with Selective Cell Culture Media

Creative Bioarray Releases GMP Grade Cytokines to Support Cell Manufacturing and Cell-based Therapies

Acroscell Develops CiPA in Silico Modeling to Identify and Optimize Drug Candidates

Chantal van Gils joins NDA Advisory Board as Director of Epidemiology and Real-World Evidence

NDA Group has announced that Chantal van Gils NDA, MD, Ph.D., specialist in epidemiological analyses and outcome research, joins the NDA Advisory Board as Director of Epidemiology and Real-World Evidence.

LIQUID STABLE & MULTI-ANALYTE CLINICAL REFERENCE MATERIALS FOR ELECTROLYTE TESTING AVAILABLE FROM VERICHEM

Shimmer Research Launches the Verisense Digital Health Panel to Create a Universal, Device Independent, Ground Truth Dataset to Accelerate Digital Health

The DHP will systematically collect raw digital health data to facilitate collaboration and accelerate the progress of digital health technologies.

SERA PROGNOSTICS ANNOUNCES PUBLICATION OF DATA PREDICTING CLINICAL UTILITY AND COST EFFECTIVENESS OF THE PRETRM® TEST-AND-TREAT STRATEGY ACROSS DIVERSE POPULATIONS

Proscia To Showcase Improvements In Artificial Intelligence Generalization At The Conference On Neural Information Processing Systems

Retrospective study demonstrated 56.3% increase in melanoma detection sensitivity through use of contrastive self-supervised learning